Evidence map›Paper›PMID 38310187›Full record

ArticleActa neuropathologica2024

New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis.

Yong Guo, Verena Endmayr, Anastasia Zekeridou, Andrew McKeon, Frank Leypoldt, Katharina Hess, Alicja Kalinowska-Lyszczarz, Andrea Klang, Akos Pakozdy, Elisabeth Höftberger and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. EBV-associated autoimmune glial fibrillary acidic protein astrocytopathy with lumbosacral leptomeningeal enhancement: a case report and literature review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 4 countries.

Yong Guo *Department of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Verena Endmayr *Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Anastasia ZekeridouDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Andrew McKeonDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Frank LeypoldtInstitute of Clinical Chemistry, University Medical Center Schleswig-Holstein Kiel, Lübeck, Germany.
Katharina HessInstitute of Neuropathology, University Hospital Muenster, Muenster, North Rhine Westphalia, Germany.
Alicja Kalinowska-LyszczarzDepartment of Neurology, Division of Neurochemistry and Neuropathology, Poznan University of Medical Sciences, Poznań, Poland.
Andrea KlangInstitute of Pathology, University of Veterinary Medicine, Vienna, Austria.
Akos PakozdyInternal Medicine, University Clinic for Small Animals, University of Veterinary Medicine, Vienna, Austria.
Elisabeth HöftbergerInternal Medicine, University Clinic for Small Animals, University of Veterinary Medicine, Vienna, Austria.
Simon HametnerDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Carmen HaiderDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Désirée De SimoniDivision of Neurology, Karl Landsteiner University of Health Sciences, University Hospital, St. Pölten, Austria.
Sönke PetersClinic for Radiology and Neuroradiology, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.
Ellen GelpiDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Christoph RöckenDepartment of Pathology, University Medical Center Schleswig-Holstein, Kiel, Germany.
Stefan OberndorferDivision of Neurology, Karl Landsteiner University of Health Sciences, University Hospital, St. Pölten, Austria.
Hans LassmannCenter for Brain Research, Medical University of Vienna, Vienna, Austria.
Claudia F Lucchinetti *Department of Neurology, Mayo Clinic, Rochester, MN, 55905, USA. clucchinetti@mayo.edu.
Romana Höftberger *Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. romana.hoeftberger@meduniwien.ac.at.ORCID 0000-0002-5769-1100
Medical University of Vienna · ATMayo Clinic · USUniversity of Veterinary Medicine Vienna · ATKarl Landsteiner University of Health Sciences · ATUniversity Hospital Schleswig-Holstein · DEChristian-Albrechts-Universität zu Kiel · DEPoznan University of Medical Sciences · PLUniversity Hospital Münster · DE

Funding

Seronegative Autoimmune Encephalopathies: Biomarker Discovery, Validation & Deep PhenotypingR01NS126227 · NINDS · MAYO CLINIC ROCHESTER · PI Andrew McKeon · 2022 to 2026
$1.9M
Austrian Science Fund FWF I 4685NINDS NIH HHS R01 NS126227
6 · The paper itself

Abstract

Anti-glial fibrillary acidic protein (GFAP) meningoencephalomyelitis (autoimmune GFAP astrocytopathy) is a new autoimmune central nervous system (CNS) disease diagnosable by the presence of anti-GFAP autoantibodies in the cerebrospinal fluid and presents as meningoencephalomyelitis in the majority of patients. Only few neuropathological reports are available and little is known about the pathogenic mechanisms. We performed a histopathological study of two autopsies and nine CNS biopsies of patients with anti-GFAP autoantibodies and found predominantly a lymphocytic and in one autopsy case a granulomatous inflammatory phenotype. Inflammatory infiltrates were composed of B and T cells, including tissue-resident memory T cells. Although obvious astrocytic damage was absent in the GFAP-staining, we found cytotoxic T cell-mediated reactions reflected by the presence of CD8

Indexed as

Autoimmune Diseases of the Nervous SystemEncephalomyelitisMeningoencephalitisAnimalsAstrocytesAutoantibodiesDogsGlial Fibrillary Acidic ProteinHumansAutoantibodiesGlial Fibrillary Acidic ProteinAutoimmunityAutopsiesBiopsiesGFAPMagnetic resonance imaging

Identifiers

PMID38310187
PMCPMC10838242
OpenAlexW4391515639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.